Weight Loss Drugs Could Prop Up Manufacturing Construction -- Market Talk

Dow Jones

Jul 18

1455 ET - For manufacturing construction companies, such as Jacob Solutions and Fluor, EV plants are out and GPL-1 factories are in. Multibillion EV and semiconductor projects are close to being completed, but investment by pharmaceutical companies, boosted by huge demand for weight loss drugs, could fill the upcoming revenue void for the construction industry, say UBS analysts in a research note. The analysts estimate $280 billion committed by pharmaceutical companies to manufacturing construction in the next four to five years, which would add 0.5% to 1% growth in both 2026 and 2027 to non-residential construction spending. The investments will help pharma companies avoid tariffs while ramping up production of weight loss drugs. (nicholas.miller@wsj.com)

(END) Dow Jones Newswires

July 17, 2025 14:55 ET (18:55 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2552439643"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2552439643\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2552439643?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-18 02:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2552439643","market":"fut","top_or_hot":-1,"title":"Weight Loss Drugs Could Prop Up Manufacturing Construction -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1455 ET - For manufacturing construction companies, such as Jacob Solutions and <a href=\"https://laohu8.com/S/FLR\">Fluor</a>, EV plants are out and GPL-1 factories are in. Multibillion EV and semiconductor projects are close to being completed, but investment by pharmaceutical companies, boosted by huge demand for weight loss drugs, could fill the upcoming revenue void for the construction industry, say UBS analysts in a research note. The analysts estimate $280 billion committed by pharmaceutical companies to manufacturing construction in the next four to five years, which would add 0.5% to 1% growth in both 2026 and 2027 to non-residential construction spending. The investments will help pharma companies avoid tariffs while ramping up production of weight loss drugs. (nicholas.miller@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 17, 2025 14:55 ET (18:55 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Weight Loss Drugs Could Prop Up Manufacturing Construction -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWeight Loss Drugs Could Prop Up Manufacturing Construction -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-18 02:55</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1455 ET - For manufacturing construction companies, such as Jacob Solutions and <a href=\"https://laohu8.com/S/FLR\">Fluor</a>, EV plants are out and GPL-1 factories are in. Multibillion EV and semiconductor projects are close to being completed, but investment by pharmaceutical companies, boosted by huge demand for weight loss drugs, could fill the upcoming revenue void for the construction industry, say UBS analysts in a research note. The analysts estimate $280 billion committed by pharmaceutical companies to manufacturing construction in the next four to five years, which would add 0.5% to 1% growth in both 2026 and 2027 to non-residential construction spending. The investments will help pharma companies avoid tariffs while ramping up production of weight loss drugs. (nicholas.miller@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 17, 2025 14:55 ET (18:55 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"J","symbol_name":"雅各布工程","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2552439643","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2552439643","pubTimestamp":1752778500,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1455 ET - For manufacturing construction companies, such as Jacob Solutions and Fluor, EV plants are out and GPL-1 factories are in. Multibillion EV and semiconductor projects are close to being completed, but investment by pharmaceutical companies, boosted by huge demand for weight loss drugs, could fill the upcoming revenue void for the construction industry, say UBS analysts in a research note. The analysts estimate $280 billion committed by pharmaceutical companies to manufacturing construction in the next four to five years, which would add 0.5% to 1% growth in both 2026 and 2027 to non-residential construction spending. The investments will help pharma companies avoid tariffs while ramping up production of weight loss drugs. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"J":"雅各布工程","FLR":"福陆","BK4588":"碎股","BK4123":"调查和咨询服务","BK4585":"ETF&股票定投概念","BK4129":"建筑与工程"},"translate_title":"减肥药可以支撑制造业建设——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FLR":0.9,"J":0.9},"content_text":"1455 ET - For manufacturing construction companies, such as Jacob Solutions and Fluor, EV plants are out and GPL-1 factories are in. Multibillion EV and semiconductor projects are close to being completed, but investment by pharmaceutical companies, boosted by huge demand for weight loss drugs, could fill the upcoming revenue void for the construction industry, say UBS analysts in a research note. The analysts estimate $280 billion committed by pharmaceutical companies to manufacturing construction in the next four to five years, which would add 0.5% to 1% growth in both 2026 and 2027 to non-residential construction spending. The investments will help pharma companies avoid tariffs while ramping up production of weight loss drugs. (nicholas.miller@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 17, 2025 14:55 ET (18:55 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}